Medtronic’s analysis featured 8,019 participants less than seven years old, who were previously on the MiniMed 770G system ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Medtronic is offering a peek into its ongoing, at-home trial of people with Parkinson’s disease being treated with adaptive ...

Medtronic has faced difficulties since the large Covidien acquisition revolving around operational execution and a lack of innovation. The firm faced an FDA warning letter for Its MiniMed 600 ...

A month has gone by since the last earnings report for Medtronic (MDT). Shares have added about 0.7 ... U.S. revenues grew in the mid-teens on the continued adoption of the MiniMed 780G automated ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Medtronic delivered a strong first-quarter ... agencies and are now capturing market adoption. That includes the MiniMed 780G automated insulin delivery (AID) system, cleared by the U.S. Food ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...

The recent boost is partly due to Medtronic's newest insulin pump, the MiniMed 780G, which earned clearance in the U.S. in April 2023. One of this device's biggest perks is that it features an ...

Shares of Medtronic PLC MDT advanced 1.52% to $89.47 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...